<bill session="105" type="h" number="2046" updated="2013-07-14T18:50:23-04:00">
  <state datetime="1997-06-25">REFERRED</state>
  <status>
    <introduced datetime="1997-06-25"/>
  </status>
  <introduced datetime="1997-06-25"/>
  <titles>
    <title as="introduced" type="official">To suspend temporarily the duty on the production of anti-cancer drugs.</title>
  </titles>
  <sponsor id="400256"/>
  <cosponsors/>
  <actions>
    <action state="REFERRED" datetime="1997-06-25">
      <text>Referred to the House Committee on Ways and Means.</text>
    </action>
    <action datetime="1997-07-02">
      <text>Referred to the Subcommittee on Trade.</text>
      <committee name="House Committee on Ways and Means"/>
    </action>
    <action datetime="1997-07-02">
      <text>See H.R.2622.</text>
      <committee name="House Committee on Ways and Means"/>
    </action>
  </actions>
  <committees>
    <committee code="HSWM" name="House Ways and Means" activity="Referral, In Committee"/>
    <committee activity="Referral" code="HSWM04" subcommittee="Trade" name="House Ways and Means"/>
  </committees>
  <relatedbills>
    <bill relation="unknown" session="105" type="h" number="2622"/>
  </relatedbills>
  <subjects>
    <term name="Foreign trade and international finance"/>
    <term name="Cancer"/>
    <term name="Chemotherapy"/>
    <term name="Drugs"/>
    <term name="Health"/>
    <term name="Tariff"/>
  </subjects>
  <amendments/>
  <summary>6/25/1997--Introduced.
Amends the Harmonized Tariff Schedule of the United States to suspend, through December 31, 2000, the duty on 2-amino-5-bromo-6-methyl-4 (1H)-quinazolinone (anti-cancer drug).</summary>
</bill>
